Relationships Between Cell-Free DNA and Serum Analytes in the First and Second Trimesters of Pregnancy
- 1 September 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 116 (3) , 673-678
- https://doi.org/10.1097/aog.0b013e3181ea2dd1
Abstract
OBJECTIVE: To assess the relationship between first- and second-trimester cell-free DNA levels and maternal serum screening markers. METHODS: First- and second-trimester residual maternal serum samples from 50 women were obtained. First-trimester (pregnancy-associated plasma protein A and β-hCG) and second-trimester serum analytes (β-hCG, alpha-fetoprotein, unconjugated estriol, and inhibin A) had been measured at the time of sample receipt. All fetuses were male as confirmed by birth records. Cell-free DNA was extracted and measured by real-time quantitative polymerase chain reaction amplification using glyceraldehyde phosphate dehydrogenase and DYS1 as markers of total DNA and fetal DNA, respectively. Determination of linear associations between first- and second-trimester serum markers and cell-free DNA levels using Pearson correlations was performed. RESULTS: Statistically significant correlations between first-trimester pregnancy-associated plasma protein A multiples of the median and both total (r=0.36, P=.016) and fetal (r=0.41, P=.006) DNA in the first trimester were observed. There were no significant correlations between first-trimester serum human chorionic gonadotropin or any second-trimester serum marker with DNA levels. CONCLUSION: Correlation between serum pregnancy-associated plasma protein A and first-trimester circulating cell-free fetal and total DNA levels is a novel finding. Pregnancy-associated plasma protein A is a glycoprotein of placental origin, and its correlation to cell-free fetal DNA in maternal serum suggests a common tissue origin through apoptosis of placental cells. However, because pregnancy-associated plasma protein A and cell-free DNA were only marginally correlated and cell-free DNA can be reliably detected in the first trimester, the addition of cell-free DNA to serum screening strategies may be helpful in predicting adverse pregnancy outcome. LEVEL OF EVIDENCE: IIKeywords
This publication has 32 references indexed in Scilit:
- The Impact of First-Trimester Serum Free β-Human Chorionic Gonadotropin and Pregnancy-Associated Plasma Protein A on the Diagnosis of Fetal Growth Restriction and Small for Gestational Age InfantFetal Diagnosis and Therapy, 2009
- Smoking in pregnancy is associated with increased total maternal serum cell‐free DNA levelsPrenatal Diagnosis, 2008
- Trophoblastic Oxidative Stress and the Release of Cell-Free Feto-Placental DNAThe American Journal of Pathology, 2006
- Cross‐trimester marker ratios in prenatal screening for Down syndromePrenatal Diagnosis, 2006
- Fetal Cells and Cell Free Fetal Nucleic Acids in Maternal Blood: New Tools to Study Abnormal Placentation?Placenta, 2005
- Maternal serum pregnancy-associated plasma protein-A and free β-human chorionic gonadotrophin in pregnancies conceived with fresh and frozen-thawed embryos fromin vitro fertilization and intracytoplasmic sperm injectionPrenatal Diagnosis, 2005
- First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: A population-based screening study (The FASTER Trial)American Journal of Obstetrics and Gynecology, 2004
- Repeated measures screening for Down's SyndromeBJOG: An International Journal of Obstetrics and Gynaecology, 2004
- Fetal Cell‐Free Nucleic Acids in the Maternal Circulation: New Clinical ApplicationsAnnals of the New York Academy of Sciences, 2004
- Interlaboratory Comparison of Fetal Male DNA Detection from Common Maternal Plasma Samples by Real-Time PCRClinical Chemistry, 2004